1. Tumour escape from the immune response

   • G. Pawelec

   Editorial 08 June 2004 Pages: 843 - 843

2. Escape from immunotherapy: possible mechanisms that influence tumor regression/progression

   • Murrium Ahmad
   • Robert C. Rees
   • Selman A. Ali

   Review 10 June 2004 Pages: 844 - 854

   

3. The paradox of T cell–mediated antitumor immunity in spite of poor clinical outcome in human melanoma

   • Andrea Anichini
   • Claudia Vegetti
   • Roberta Mortarini

   Review 03 June 2004 Pages: 855 - 864

   

4. Down-regulation of ζ-chain expression in T cells: a biomarker of prognosis in cancer?

   • Theresa L. Whiteside

   Review 29 April 2004 Pages: 865 - 878

   

5. Effective immunotherapy against cancer

   • Karl-Johan Malmberg

   Review 28 July 2004 Pages: 879 - 892

6. Targeting of tumor cells by lymphocytes engineered to express chimeric receptor genes

   • Constantin N. Baxevanis
   • Michael Papamichail

   Review 26 May 2004 Pages: 893 - 903

   

7. The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape

   • Ignacio Algarra
   • Angel García-Lora
   • Federico Garrido

   Review 07 April 2004 Pages: 904 - 910

   

8. Expression of NK-associated receptors on cytotoxic T cells from melanoma patients: a two-edged sword?

   • Raquel Tarazona
   • Javier G. Casado
   • Rafael Solana

   Review 04 May 2004 Pages: 911 - 924

   

9. Replicative senescence of CD8 T cells: potential effects on cancer immune surveillance and immunotherapy

   • Rita B. Effros

   Review 06 April 2004 Pages: 925 - 933